Skip to content

Gritstone bio, Inc.

CIK 0001656634

Revenue (TTM)
$6.18M
−18.1% YoY Q2 Aug 2024
Net Income (TTM)
−$137.47M
−15.7% YoY Q2 Aug 2024
EPS Diluted (TTM)
−$1.14
+9.1% YoY Q2 Aug 2024
Gross Margin
Q2 Aug 2024
Operating Margin
-2,292.1%
Q2 Aug 2024
Net Margin
-2,223.4%
Q2 Aug 2024
Free Cash Flow (TTM)
−$100.97M
Q2 Aug 2024
Cash
$50.9M
Q2 Aug 2024
Total Debt
$40.51M
Q2 Aug 2024
Shares Outstanding
118.11M sh
Q2 Aug 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings